What if surgeons could see blood flow—without the old-school green dye?
ViewFlow’s smart camera lets surgeons spot blood flow live during surgery—no dyes needed. A game-changer for 100M operations/year in a billion-dollar market, with 3 hospitals already waiting.
If you’ve heard about ViewFlow.AI from us or an article, here’s the simple why: Surgeons can’t see live blood flow reliably. ViewFlow fixes that—fast, no mess. It’s like giving doctors X-ray vision for blood vessels, saving lives and cutting costs. For you, it’s a chance to back something meaningful with solid upside.
The Big Miss
96% skip flow checks
5-20% end with poor flow
Billion $ Market
Hospitals Want It
$300M-$600M Exit Path
Massive Problem
1 in 5 bypass too slow. 1 in 7 flaps die. Dr. Vip Patel: “#1 issue.”
Easy Breakthrough
Point, see live vessel flow—world first. vision algorithms, not ’60s dye. Dr. Theodoro: “Can’t op without it.”
Your Return
Goals: $250K/hosp Y1 → $750K. 20x $30M REV = $600M. Exit Y4. Tops Novadaq (dye). 5-10x return
FDA Surgical Camera. 3 Hospitals ready for clinical programs (Houston, Duke, Rex-UNC).
Can share in viewflow’s savings to hospitals and payers: compounds shareholders’ value.
Pros who’ve built & sold health-tech hits.
Jim Sund, CEO
Duke PhD/MBA | NASA Fellow | Licensed to Roche & Merck | “Exit path to $500M+”
Randall Wolf, MD
DeBakey Heart | “Data-driven wins.”
Kim Steinmann, MD
Studies Lead | “Helpful across diverse surgeries”
Dennis Robbins, PhD, MPH
Managed Care Markets
ViewFlow isn’t just new tech—It’s about getting people back to their lives faster.
Fewer complications mean quicker recoveries and happier families.
Imagine helping save a loved one’s heart surgery—your investment makes that possible.
“Investing in ViewFlow was easy and exciting—I love knowing my money helps real people recover faster.” – John D., Teacher & Occasional Investor
Final $600K of $5M. SAFE 20% discount. Min $15K cash ($50K IRA). Funds: pilots, pubs, sales. Next: $10M+ (Series B). Exit goal Y4: $600M.
Or Info drop here. Routes to Investor Relations.